Xenetic Biosciences (XBIO) Assets (2011 - 2026)
Xenetic Biosciences' Assets was $6.97 million in Q2 2026, up 30.2% from $5.35 million a year earlier but down 11.9% from the prior quarter.
Powered by 
Analysis
Xenetic Biosciences (XBIO) Assets (2011 - 2026) Analysis & Trends
At the end of FY2025, Assets at Xenetic Biosciences came in at $8.36 million, up 21.2% from FY2024.
- Assets shows a five-year compound annual growth rate of -8.7% (FY2020 to FY2025).
- In earlier years, Assets was $6.9 million in FY2024 (-34.9%), $10.61 million in FY2023 (-28.0%), $14.72 million in FY2022 (-25.7%) and $19.82 million in FY2021 (+50.3%).
- Quarterly Assets has moved between $5.07 million (Q3 2025) and $21.29 million (Q3 2021) over five years.
- Compared with a year earlier, Assets has increased for three straight quarters, with an average decline of 12.0% over the last eight quarters.
- The best year-over-year quarter for Assets over five years was Q3 2021 (growth of 144.8%); the worst was Q2 2025 (a decline of 40.7%).
- Per Business Quant data, XBIO's Assets in the three quarters before Q2 2026 was $7.91 million (Q1 2026), $8.36 million (Q4 2025) and $5.07 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Xenetic Biosciences | 5.25 Mn | -20.58 Mn | - | 6.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.97 Mn |
| Mar 31, 2026 | 7.91 Mn |
| Dec 31, 2025 | 8.36 Mn |
| Sep 30, 2025 | 5.07 Mn |
| Jun 30, 2025 | 5.35 Mn |
| Mar 31, 2025 | 5.79 Mn |
| Dec 31, 2024 | 6.90 Mn |
| Sep 30, 2024 | 8.05 Mn |
| Jun 30, 2024 | 9.03 Mn |
| Mar 31, 2024 | 9.39 Mn |
| Dec 31, 2023 | 10.61 Mn |
| Sep 30, 2023 | 11.96 Mn |
| Jun 30, 2023 | 12.75 Mn |
| Mar 31, 2023 | 13.72 Mn |
| Dec 31, 2022 | 14.72 Mn |
| Sep 30, 2022 | 15.57 Mn |
| Jun 30, 2022 | 16.47 Mn |
| Mar 31, 2022 | 17.98 Mn |
| Dec 31, 2021 | 19.82 Mn |
| Sep 30, 2021 | 21.29 Mn |
API Access
Xenetic Biosciences Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=XBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "XBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=XBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();